Nrf2-deficient female mice develop lupus-like autoimmune nephritis. - Wikidata - awgldk - TriplyDB

Nrf2-deficient female mice develop lupus-like autoimmune nephritis.

Nrf2-deficient female mice develop lupus-like autoimmune nephritis.

http://www.wikidata.org/entity/Q43750335

about

Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2 Role of Nrf2 in oxidative stress and toxicity Accelerated ovarian failure induced by 4-vinyl cyclohexene diepoxide in Nrf2 null mice Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2 Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2.Effect of redox modulating NRF2 activators on chronic kidney disease NF-κB in inflammation and renal diseases Mechanisms of action of isothiocyanates in cancer chemoprevention: an update Genetic variation at a Yin-Yang 1 response site regulates the transcription of cyclin-dependent kinase inhibitor p18INK4C transcript in lupus-prone mice Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria Stress-activated cap'n'collar transcription factors in aging and human disease CACUL1/CAC1 Regulates the Antioxidant Response by Stabilizing Nrf2 The Nrf2 activator tBHQ inhibits T cell activation of primary human CD4 T cells Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA)Regulation of APC development, immune response, and autoimmunity by Bach1/HO-1 pathway in mice Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters The Nrf2 activator, tBHQ, differentially affects early events following stimulation of Jurkat cells Nrf2 regulates chronic lung inflammation and B-cell responses to nontypeable Haemophilus influenzae The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism Regulation of proteasome activity in health and disease NF-E2-related factor 2 regulates the stress response to UVA-1-oxidized phospholipids in skin cells.Citral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of NLRP3 inflammasome and enhancing Nrf2 activation Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription Repression of the Antioxidant NRF2 Pathway in Premature Aging Nuclear Factor Erythroid 2-related Factor 2 Deficiency Exacerbates Lupus Nephritis in B6/lpr mice by Regulating Th17 Cell Function Th2 skewing by activation of Nrf2 in CD4(+) T cells Catalase prevents maternal diabetes-induced perinatal programming via the Nrf2-HO-1 defense system Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1 Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription.Oxidative stress in the pathology and treatment of systemic lupus erythematosus The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease.Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver.Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity.Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.

P2860

Q23919668-804E8387-CDEB-47BF-B97D-8255BB3D0F66 Q23919669-45EC07C1-FC6E-4BD1-BFEF-29059C73688B Q23923904-E99D1358-BC26-45B4-BB5A-C85D1139BEC9 Q24170511-F4E53495-B6B5-41D8-8304-954BF736BD0A Q24529933-5D4B9864-B704-493A-B820-0BB3510D9BB6 Q24559743-8BB0983D-D3E2-4382-B73E-E9B7329A5CCC Q24606271-17D0FC62-9FD0-4A21-81E5-B35F35703CB1 Q26827726-70DFD8AC-9E6A-45DE-B3A0-2CB6135F8D50 Q27021276-D4CFD4A7-91AC-4C50-9E1C-0A3B5A6A79E6 Q28248643-92C12594-4018-4D67-B19F-510D3C0D766D Q28384061-E0455B6A-5B00-40D3-A699-B96E7870152D Q28384306-C27A0B7B-E5E3-49B2-A59E-100F65593DC5 Q28384526-E9A213F8-E757-459E-8D5A-E32238DE850D Q28384783-65D4D6BA-B242-4626-B64E-ADC3CFACC8D7 Q28384997-0CFEB572-5A97-4438-BC9C-18DAECF792D2 Q28385998-AE006C6F-CED1-4F51-B0F0-E4FCAED33A4D Q28387231-3A8FCA6B-2E16-49BC-8F42-81B8F333A87B Q28387350-C327F857-A020-4A42-8634-539738084BF6 Q28388916-2DA491EE-A2CF-4BF3-A3C0-B786933D35DB Q28389828-73FD5C3F-0346-4AD6-BA7F-15FFF2D81E65 Q28391095-D195F06F-CFBF-4BC8-BB64-26F1D3C9EE12 Q28392051-49704B89-C2FD-40FA-B348-9B8B73E946F2 Q28392347-803D0C80-B6CB-4751-BA37-252D175CCF1F Q28392708-CF2439CC-FAD4-4AC2-ABB6-452C39D3BA63 Q28392832-EAFDE745-049E-43AB-9419-E39FC9DAB8F2 Q28394337-739E78C8-5DB3-49E5-90FA-949662C1FBF3 Q28395088-CE17F5CC-46C9-4BE7-8EDF-F131D6BA241C Q28396013-ABA3B4C4-9562-4AAD-89B7-8A623731F2CA Q28396263-3B076FC9-698E-4074-AFD3-D8D48E3AA9D4 Q28396391-915D8D2C-D94E-4826-9EC7-341164C938DA Q28578371-351BF832-A436-47FC-98DA-90ABDEDAF1B1 Q28583647-FDD782D5-FFB4-41F6-BDDF-81960558E56F Q29617845-00AEAD19-23CE-433B-A8D6-88E50A5CF143 Q30495467-7CAF62D0-EDDC-4D91-9376-545BFC4DAD73 Q33551416-B00D2F40-8E4F-4962-80FF-6523C41B3E90 Q33715508-72C20FBF-4D93-4F2F-B902-69464A2B8871 Q33716356-5E207ACA-26D7-4A89-AF7C-543140179CA5 Q33939951-641FBEB1-51AB-4CBA-8E82-0EF5E2C1CBDC Q34214639-41CB9AAC-A473-44BD-A245-A86B519567D0 Q34415403-C907B5AA-D6D8-449B-BE2A-E37AAA897A71

P2860

Nrf2-deficient female mice develop lupus-like autoimmune nephritis.

http://www.wikidata.org/entity/Q43750335

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Nrf2-deficient female mice develop lupus-like autoimmune nephritis.

@en

Nrf2-deficient female mice develop lupus-like autoimmune nephritis.

@nl

type

label

Nrf2-deficient female mice develop lupus-like autoimmune nephritis.

@en

Nrf2-deficient female mice develop lupus-like autoimmune nephritis.

@nl

prefLabel

Nrf2-deficient female mice develop lupus-like autoimmune nephritis.

@en

Nrf2-deficient female mice develop lupus-like autoimmune nephritis.

@nl

P1433

Q43750335-C708A865-2EAA-429F-85E9-604559BF057D

P1476

Q43750335-E90B4455-8AEE-431C-A5D1-6100480AA6AB

P2093

Q43750335-2ECAEDB4-65E0-4FEE-86DD-19537FFFFA1E

Q43750335-3237A3D5-40E8-4443-A2D0-DCF39F4B166F

Q43750335-6B2EBA4B-002E-4457-A3F8-3E0CF8AAFF6B

Q43750335-6D929FC6-4A3C-4FB7-9EC6-2CE3812CA7C6

Q43750335-6FDABA8B-20DF-47E9-A486-03C167CEC738

Q43750335-95665DB6-E630-4E3E-B45D-D3FAD1F14C1D

Q43750335-A8441191-D62F-496B-9284-FDE88824350F

Q43750335-BB833156-9CF9-4266-B44E-30CAD30CAF37

Q43750335-BBC4DB2D-238E-4D0A-A83C-E79F2EAE6D81

Q43750335-DEF282FB-4212-4F19-9FEF-934463DDA12A

P2888

Q43750335-06DE8D12-7E9F-4802-AA81-EEE6C94B8A58

P304

Q43750335-FDA4BAE1-C359-44BD-B952-72766C42C9C2

P31

Q43750335-A14920DD-1992-4C64-969E-A895A3C31557

P356

Q43750335-FAB2492B-8B3E-4D90-84D7-AC243D172676

P407

Q43750335-59CAC45A-C916-4465-9BE5-4475B6C742AF

P433

Q43750335-44E8FBBB-4C69-4CEE-9BD2-0AE62CCAFAF6

P478

Q43750335-56232DF3-DBCF-4C6E-AB00-120B9A72C647

P577

Q43750335-C0C4029F-B6E6-4C3D-995E-391E6F285E60

P6179

Q43750335-34C49D63-52EF-4047-811F-3B7D13A79FFD

P698

Q43750335-FEB9F744-6E06-4CF3-AE3A-8A99CE76F243

P356

J.1523-1755.2001.00939.X

P1433

Kidney International

P1476

Nrf2-deficient female mice develop lupus-like autoimmune nephritis.

@en

P2093

Enomoto A

http://www.w3.org/2001/XMLSchema#string

Hirayama A

http://www.w3.org/2001/XMLSchema#string

Itoh K

http://www.w3.org/2001/XMLSchema#string

Kobayashi M

http://www.w3.org/2001/XMLSchema#string

Koyama A

http://www.w3.org/2001/XMLSchema#string

Morito N

http://www.w3.org/2001/XMLSchema#string

Takahashi S

http://www.w3.org/2001/XMLSchema#string

Yamaguchi N

http://www.w3.org/2001/XMLSchema#string

Yamamoto M

http://www.w3.org/2001/XMLSchema#string

Yoh K

http://www.w3.org/2001/XMLSchema#string

P2888

j.1523-1755.2001.00939.x

P304

1343-1353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1523-1755.2001.00939.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1006863434

http://www.w3.org/2001/XMLSchema#string

P698

11576348

http://www.w3.org/2001/XMLSchema#string